BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 16 filers reported holding BIOANALYTICAL SYS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $101,000 | +16.1% | 50,341 | +17.5% | 0.16% | +8.8% |
Q1 2015 | $87,000 | -6.5% | 42,841 | 0.0% | 0.15% | -2.6% |
Q4 2014 | $93,000 | -5.1% | 42,841 | +1.5% | 0.15% | -11.6% |
Q3 2014 | $98,000 | +22.5% | 42,208 | +33.0% | 0.17% | +22.0% |
Q2 2014 | $80,000 | 0.0% | 31,736 | 0.0% | 0.14% | -16.6% |
Q1 2014 | $80,000 | – | 31,736 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ESSEX INVESTMENT MANAGEMENT CO LLC | 95,872 | $481,000 | 0.08% |
Versant Capital Management, Inc | 19,191 | $97,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 67,510 | $343,000 | 0.01% |
NORTH STAR ASSET MANAGEMENT INC | 10,000 | $50,000 | 0.00% |
Renaissance Technologies | 503,406 | $2,525,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 63,849 | $321,000 | 0.00% |
tru Independence LLC | 1,100 | $6,000 | 0.00% |
VANGUARD GROUP INC | 449,627 | $2,255,000 | 0.00% |
UBS Group AG | 13,660 | $69,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |